In the setting of epinephrine use for anaphylaxis under ICEMA standing orders, what is the priority?

• A. Administer a second dose immediately without monitoring
• B. Treat and send patient to hospital without monitoring
• C. Data collection only
• D. Monitoring should be continuous with airway, breathing, and circulation assessment under medical control

Answer: (D)

The priority in epinephrine use for anaphylaxis under ICEMA standing orders is to maintain continuous monitoring of the patient’s airway, breathing, and circulation under medical control. Anaphylaxis can progress rapidly, and although epinephrine can reverse symptoms, the patient’s condition can deteriorate suddenly due to airway edema, bronchospasm, hypotension, or arrhythmias. Continuous assessment with vital signs (including oxygen saturation, blood pressure, and heart rate) and airway status allows immediate recognition of worsening or improvement and guides timely decisions for additional treatment, airway management, or escalation under medical control.

Choosing to administer a second dose without monitoring or to proceed without ongoing reassessment neglects the risk of rapid deterioration and potential need for further intervention. Relying on data collection alone delays essential, life-saving care and does not address the patient’s immediate safety.